DK1663347T3 - Afereseindretning - Google Patents

Afereseindretning

Info

Publication number
DK1663347T3
DK1663347T3 DK04761033T DK04761033T DK1663347T3 DK 1663347 T3 DK1663347 T3 DK 1663347T3 DK 04761033 T DK04761033 T DK 04761033T DK 04761033 T DK04761033 T DK 04761033T DK 1663347 T3 DK1663347 T3 DK 1663347T3
Authority
DK
Denmark
Prior art keywords
apheresis device
apharesis
contacted
plasma
blood
Prior art date
Application number
DK04761033T
Other languages
Danish (da)
English (en)
Inventor
Walter Schmidt
Frank Mattner
Original Assignee
Affiris Forschungs & Entwicklungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1663347(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affiris Forschungs & Entwicklungs Gmbh filed Critical Affiris Forschungs & Entwicklungs Gmbh
Application granted granted Critical
Publication of DK1663347T3 publication Critical patent/DK1663347T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
DK04761033T 2003-09-12 2004-09-13 Afereseindretning DK1663347T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0144403A AT413336B (de) 2003-09-12 2003-09-12 Apherese-vorrichtung
PCT/AT2004/000311 WO2005025651A1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung

Publications (1)

Publication Number Publication Date
DK1663347T3 true DK1663347T3 (da) 2008-05-19

Family

ID=34280361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04761033T DK1663347T3 (da) 2003-09-12 2004-09-13 Afereseindretning

Country Status (15)

Country Link
US (2) US7935252B2 (enExample)
EP (1) EP1663347B1 (enExample)
JP (1) JP4509113B2 (enExample)
CN (1) CN100556472C (enExample)
AT (2) AT413336B (enExample)
AU (1) AU2004271651B2 (enExample)
CA (1) CA2538305C (enExample)
CY (1) CY1107911T1 (enExample)
DE (1) DE502004005851D1 (enExample)
DK (1) DK1663347T3 (enExample)
ES (1) ES2298789T3 (enExample)
HR (1) HRP20080090T3 (enExample)
PL (1) PL1663347T3 (enExample)
PT (1) PT1663347E (enExample)
WO (1) WO2005025651A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056318A2 (en) 2002-12-19 2004-07-08 New York University Method for treating amyloid disease
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) * 2005-03-15 2006-10-15 Mattner Frank Dr Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) * 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
EP2237804B1 (en) * 2007-12-21 2013-04-10 GE Healthcare Bio-Sciences AB Method for sterilization of chemically activated solid support materials
US20100030196A1 (en) * 2008-07-29 2010-02-04 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
WO2010073580A1 (ja) * 2008-12-22 2010-07-01 学校法人藤田学園 Aβ除去材、Aβ除去器及びAβ除去システム
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
DK2579042T3 (da) 2011-10-04 2014-07-21 Affiris Ag Fremgangsmåde til at påvise Aß-specifikke antistoffer i en biologisk prøve
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
AU2015286606A1 (en) * 2014-07-10 2017-01-12 Affiris Ag Substances and methods for the use in prevention and/or treatment in huntington's disease
EP3166966A1 (en) 2014-07-10 2017-05-17 Affiris AG Substances and methods for the use in prevention and/or treatment in huntington's disease
JP7368856B2 (ja) 2017-07-25 2023-10-25 トゥルーバインディング，インコーポレイテッド Ｔｉｍ－３とそのリガンドとの相互作用の遮断によるがん治療
CN116063505B (zh) 2019-01-30 2024-05-03 真和制药有限公司 抗gal3抗体及其用途
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
US12281166B2 (en) 2020-05-26 2025-04-22 Truebinding, Inc. Methods of treating inflammatory diseases by blocking Galectin-3

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
JPH06104122B2 (ja) * 1985-09-19 1994-12-21 東レ株式会社 β▲下２▼−ミクログロブリン除去カラム
US5216127A (en) * 1987-11-20 1993-06-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for serum amyloid protein
JPH01171638A (ja) * 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
DE3853219T2 (de) * 1987-11-20 1995-06-29 Kanegafuchi Chemical Ind Methode zur Entfernung von Serum-Amyloid-Protein.
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja) 1992-09-21 1994-04-15 Matsushita Electric Ind Co Ltd ロータリートランス
CA2190268C (en) 1994-05-13 2000-01-25 Wolfgang Bohm Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
DE19549420A1 (de) * 1995-04-27 1997-09-18 Braun Melsungen Ag Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose Faktor alpha (TNF alpha) und bakteriellen Lipopolysacchariden (LPS) aus Vollblut oder/und Blutplasma
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
SI1257584T2 (sl) * 2000-02-24 2013-07-31 Washington University St. Louis Humanizirana protitelesa, ki veĹľejo amiloidni peptid beta
TWI238251B (en) * 2000-07-13 2005-08-21 Anawrhta Biotech Co Ltd In-vitro adsorbing device using immunity
WO2003051374A2 (en) * 2001-12-17 2003-06-26 New York State Office Of Mental Health SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
WO2004056318A2 (en) * 2002-12-19 2004-07-08 New York University Method for treating amyloid disease
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh Cholinestertransport-protein-mimotop als atherosklerose-medikament

Also Published As

Publication number Publication date
ATA14442003A (de) 2005-07-15
ATE382383T1 (de) 2008-01-15
HRP20080090T3 (hr) 2008-03-31
CA2538305A1 (en) 2005-03-24
CY1107911T1 (el) 2013-09-04
CA2538305C (en) 2011-05-24
AU2004271651A1 (en) 2005-03-24
DE502004005851D1 (de) 2008-02-14
HK1096320A1 (zh) 2007-06-01
WO2005025651A1 (de) 2005-03-24
US20070026029A1 (en) 2007-02-01
PL1663347T3 (pl) 2008-06-30
US20110166327A1 (en) 2011-07-07
PT1663347E (pt) 2008-03-28
JP4509113B2 (ja) 2010-07-21
AU2004271651B2 (en) 2009-08-06
ES2298789T3 (es) 2008-05-16
EP1663347B1 (de) 2008-01-02
US7935252B2 (en) 2011-05-03
CN1867365A (zh) 2006-11-22
EP1663347A1 (de) 2006-06-07
AT413336B (de) 2006-02-15
CN100556472C (zh) 2009-11-04
JP2007504863A (ja) 2007-03-08

Similar Documents

Publication Publication Date Title
ATE382383T1 (de) Apherese-vorrichtung
IL258702B (en) A pump system for use with organ care systems
ATE474617T1 (de) Medizinproduktsysteme
DE60308293D1 (de) Blutbehandlungskathetereinrichtung
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
EP1800703A4 (en) blood dialyzer
DE602004032225D1 (de) Stromabwärts-Plasmabehandlungsgerät
BRPI0718146A2 (pt) Dispositivos de infusão e métodos
EA201000644A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DK2219642T3 (da) Silibininbestandel til behandling af hepatitis
DE602004023543D1 (de) Implantierbare medizinische vorrichtung
NO20072285L (no) S-mirtazapin for behandling av hetetokter
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
ATA13602003A (de) Therapeutisches behandlungsgerät
ATE515280T1 (de) Vorrichtung zur intermittierenden okklusion des koronarsinus
ITMI20030647A1 (it) Dispositivo per il trattamento di sangue in circolazione extracorporea
EP1913879A4 (en) MEDICAL TREATMENT DEVICE
DK1687297T3 (da) Triazindimerer til behandling af autoimmunsygdomme
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
EP1862153A4 (en) OPHTHALMIC CANNULA
FI20051207A0 (fi) Selän hoitolaite
ATE489947T1 (de) Axomadol zur schmerzbehandlung bei arthrose
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling